Screening compound: InChI=1S/C15H24N6/c1-11(2)15-17-16-13-5-6-14(18-21(13)15)20-9-7-19(8-10-20)12(3)4/h5-6,11-12H,7-10H2,1-4H3

Screening compound: InChI=1S/C15H24N6/c1-11(2)15-17-16-13-5-6-14(18-21(13)15)20-9-7-19(8-10-20)12(3)4/h5-6,11-12H,7-10H2,1-4H3
Screening compound: InChI=1S/C15H24N6/c1-11(2)15-17-16-13-5-6-14(18-21(13)15)20-9-7-19(8-10-20)12(3)4/h5-6,11-12H,7-10H2,1-4H3 alternative view

Chemical Structure Depiction of ChemDiv screening compound
InChI=1S/C15H24N6/c1-11(2)15-17-16-13-5-6-14(18-21(13)15)20-9-7-19(8-10-20)12(3)4/h5-6,11-12H,7-10H2,1-4H3

Available from 1 mg

Formats:

  • Glass Vials (4ml Glass Vials VWR #97047-678)
  • 96-tube racks (Matrix #4247 96-well 1.4ml sealed with capmats, empty cols 1 & 12, 100uL of 10mM)

Shiptime: 1 week worldwide delivery in most cases

Compound Identifiers

ChemDiv Compound ID

Z606-3935

Molecular Formula

C15H24N6 (C15 H24 N6)

Compound Name

1-(propan-2-yl)-4-[3-(propan-2-yl)-[1,2,4]triazolo[4,3-b]pyridazin-6-yl]piperazine

IUPAC name

1-(propan-2-yl)-4-[3-(propan-2-yl)-[124]triazolo[43-b]pyridazin-6-yl]piperazine

SMILES

CC(C)c1nnc(cc2)n1nc2N(CC1)CCN1C(C)C

InChI

InChI=1S/C15H24N6/c1-11(2)15-17-16-13-5-6-14(18-21(13)15)20-9-7-19(8-10-20)12(3)4/h5-6,11-12H,7-10H2,1-4H3

InChI Key

YTEWBBNRDCRWDE-UHFFFAOYSA-N

MDL Number (MFCD)

MFCD27640609

InChI=1S/C15H24N6/c1-11(2)15-17-16-13-5-6-14(18-21(13)15)20-9-7-19(8-10-20)12(3)4/h5-6,11-12H,7-10H2,1-4H3 in Drug Discovery

Included in Screening Libraries

CNS BBB Library (22607 compounds)

Fragments Library (11262 compounds)

Protein Arginine Methyltransferases Library (27925 compounds)

SmartTM Library (51161 compounds)

Soluble Diversity Library (15920 compounds)

Targeted Diversity Library (40567 compounds)

Akt-Targeted Library (14764 compounds)

Included in 1.7M Stock Database

Therapeutical areas:
  • Nervous system
  • Cancer
  • Musculoskeletal
  • Digestive system
  • Respiratory tract
  • Male
  • Female
  • Hemic and lymphatic
  • Metabolic
  • Digestive system
  • Respiratory tract
  • Male
  • Female
  • Hemic and lymphatic
  • Skin
Structure:
  • Fragments
Targets:
  • Others
  • Kinases
Mechanism of action:
  • Epigenetic

References: we are preparing a list of scientific research reports with InChI=1S/C15H24N6/c1-11(2)15-17-16-13-5-6-14(18-21(13)15)20-9-7-19(8-10-20)12(3)4/h5-6,11-12H,7-10H2,1-4H3 chemical compound. It will be published here after verification.

Frequently Asked Questions

How to purchase chemical compound InChI=1S/C15H24N6/c1-11(2)15-17-16-13-5-6-14(18-21(13)15)20-9-7-19(8-10-20)12(3)4/h5-6,11-12H,7-10H2,1-4H3?
Check Price and Availability of InChI=1S/C15H24N6/c1-11(2)15-17-16-13-5-6-14(18-21(13)15)20-9-7-19(8-10-20)12(3)4/h5-6,11-12H,7-10H2,1-4H3, then you can add required amount to the Shopping Cart. In the Shopping Cart you can again refine your selection. Once you are sure that it’s exactly what you want you can move forward with the Checkout (to pay online by credit card, or via PayPal), or Request a Quote.
What is the minimum amount of InChI=1S/C15H24N6/c1-11(2)15-17-16-13-5-6-14(18-21(13)15)20-9-7-19(8-10-20)12(3)4/h5-6,11-12H,7-10H2,1-4H3 you sell to drug discovery company or institution?
Available from 1 mg in Glass Vials or 96-tube racks.
Delivery options for InChI=1S/C15H24N6/c1-11(2)15-17-16-13-5-6-14(18-21(13)15)20-9-7-19(8-10-20)12(3)4/h5-6,11-12H,7-10H2,1-4H3
ChemDiv sends parcels with Express services (UPS, WC).
  • 1–2 days for small orders
  • 2–4 weeks for large selections
Delivery formats for InChI=1S/C15H24N6/c1-11(2)15-17-16-13-5-6-14(18-21(13)15)20-9-7-19(8-10-20)12(3)4/h5-6,11-12H,7-10H2,1-4H3
  • 0.5–50 mg of dry powder sample in single glass vials, custom vials
  • DMSO solutions frozen 10μl–250μl@10mM (96 and 384 format)

Custom synthesis of InChI=1S/C15H24N6/c1-11(2)15-17-16-13-5-6-14(18-21(13)15)20-9-7-19(8-10-20)12(3)4/h5-6,11-12H,7-10H2,1-4H3 available by request